Now enrolling people with multiple myeloma who have undergone autologous stem cell transplantation​​ (ASCT)​​. Participants in MagnetisMM-7 will advance research on a potential targeted treatment option for multiple myeloma, which could benefit future generations. For more details about the MagnetisMM-7 clinical trial, please visit: https://www.pfizerclinicaltrials.com/nct05317416-multiple-myeloma-trial?cmp=5ca0d465-6e7f-4fe9-b87d-8ed90a4bed3c&ttype=WEB